Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
4.290
-0.460 (-9.68%)
At close: Jun 18, 2026, 4:00 PM EDT
4.212
-0.078 (-1.83%)
After-hours: Jun 18, 2026, 8:00 PM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $22.22 million as of June 18, 2026.
Market Cap
22.22M
Enterprise Value
16.04M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $22.22M, a decrease of -43.66%. That is a compound annual growth rate of -65.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 22.22M | -36.35% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 64.53M |
| Daxor | 58.04M |
| Zentek | 55.49M |
| Nephros | 35.34M |
| Milestone Scientific | 30.50M |
| Harvard Bioscience | 26.70M |
| Retractable Technologies | 20.36M |
| Jin Medical International | 18.94M |